HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk
  • MJHLS Brand Logo

© 2022 MJH Life Sciences™ , NeurologyLive – Clinical Neurology News and Neurology Expert Insights. All rights reserved.

Comprehensive Management of Dravet Syndrome

Joseph Sullivan, MD, and Elaine C. Wirrell, MD, discuss the diagnosis, management, and treatment of Dravet Syndrome.

EP. 1: Presentation of Dravet Syndrome

June 23rd 2021

Joseph Sullivan, MD, and Elaine C. Wirrell, MD, discuss the presentation of Dravet syndrome in children.

EP. 2: Early Diagnosis and Seizure Triggers of Dravet Syndrome

June 23rd 2021

The importance of early diagnosis of Dravet syndrome as well as seizure triggers and comorbidities are discussed by key opinion leaders in the field.

EP. 3: Dravet Syndrome: SUDEP and Increase Risk of Premature Mortality

June 30th 2021

Elaine C. Wirrell, MD, explains the increased risk of sudden unexpected death in epilepsy (SUDEP) in patients with Dravet syndrome and how to talk about it with caregivers and families.

EP. 4: Family Planning and Behavior Issues Associated with Dravet Syndrome

June 30th 2021

Considerations of genetic testing regarding family planning as well as behavioral issues associated with Dravet syndrome.

EP. 5: Treatment Goals of Dravet Syndrome

July 7th 2021

Experts discuss the goals of treatment of patients with Dravet syndrome regarding seizure freedom and seizure burden.

EP. 6: Dravet Syndrome: Management of Treatment

July 7th 2021

Joseph Sullivan, MD, and Elaine C. Wirrell, MD, discuss the management of seizures for Dravet syndrome with different approved therapies.

EP. 7: Dravet Syndrome: Cannabidiol Oral Solution

July 13th 2021

Elaine C. Wirrell, MD, provides an overview of cannabidiol oral solution for treatment of seizures associated with Dravet syndrome.

EP. 8: Recent Approval of Fenfluramine Oral Solution

July 13th 2021

Joseph Sullivan, MD, provides an overview of the recent approval of fenfluramine oral solution for the treatment of Dravet syndrome.

EP. 9: Dravet Syndrome: Fenfluramine and the Impact on Consensus Guidelines

July 25th 2021

The impact of new drug approvals on the consensus guidelines for the treatment of Dravet syndrome.

EP. 10: Therapies in Development for Dravet Syndrome

July 25th 2021

A discussion of new developments for the treatment of Dravet syndrome beyond seizure control including gene editing and therapy.